Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention
Clinical trial NCT05016661 · TERMINATED
Trial details
- NCT number
- NCT05016661
- Sponsor
- AEON Biopharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2024-07-31
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.